These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 9657438)
21. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain. Takamiya O Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333 [TBL] [Abstract][Full Text] [Related]
22. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). O'Brien DP; Kemball-Cook G; Hutchinson AM; Martin DM; Johnson DJ; Byfield PG; Takamiya O; Tuddenham EG; McVey JH Biochemistry; 1994 Nov; 33(47):14162-9. PubMed ID: 7947828 [TBL] [Abstract][Full Text] [Related]
23. Similarities and discrepancies in homozygous factor VII defects due to mutations in the region of residues Met298 to Cys310 (exon 8) in the catalytic domain of factor VII. Girolami A; Berti de Marinis G; Bonamigo E; Vettore S Lab Hematol; 2011 Jun; 17(2):17-21. PubMed ID: 21705315 [TBL] [Abstract][Full Text] [Related]
25. Severe factor VII deficiency caused by a novel point mutation (Arg353Pro) combined with a rare Cys22Arg mutation. Zhidong W; Xiaojun H Thromb Haemost; 2007 Sep; 98(3):687-8. PubMed ID: 17849063 [No Abstract] [Full Text] [Related]
26. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X. Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706 [TBL] [Abstract][Full Text] [Related]
27. A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk. Kavlie A; Wiiger MT; Husbyn M; Stormorken H; Prydz H Thromb Haemost; 2004 Jan; 91(1):28-37. PubMed ID: 14691565 [TBL] [Abstract][Full Text] [Related]
28. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149 [TBL] [Abstract][Full Text] [Related]
29. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method. Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565 [TBL] [Abstract][Full Text] [Related]
30. [Analysis of an inherited FVII deficiency pedigree caused by homozygosity of Thr359Met]. Chu HY; Wang HL; Ding QL; Wang XF; Qu B; Wu F; Kang WY; Duan BH; Yin J; Fu QH; Wu WM; Wang ZY Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):134-7. PubMed ID: 12697124 [TBL] [Abstract][Full Text] [Related]
31. Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function. Kemball-Cook G; Johnson DJ; Takamiya O; Banner DW; McVey JH; Tuddenham EG J Biol Chem; 1998 Apr; 273(14):8516-21. PubMed ID: 9525966 [TBL] [Abstract][Full Text] [Related]
32. Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain. Leonard BJ; Chen Q; Blajchman MA; Ofosu FA; Sridhara S; Yang D; Clarke BJ Blood; 1998 Jan; 91(1):142-8. PubMed ID: 9414278 [TBL] [Abstract][Full Text] [Related]
33. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Geng JP; Castellino FJ Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404 [TBL] [Abstract][Full Text] [Related]
34. Characterization of a Cys329Gly mutation causing hereditary factor VII deficiency. Wu Y; Tu X; Lian Y; Chen F; Lan F; Zhu Z Acta Haematol; 2006; 116(2):96-100. PubMed ID: 16914903 [TBL] [Abstract][Full Text] [Related]
35. The influence of different glycosylation patterns on factor VII biological activity. Sutkeviciute I; Mistiniene E; Sereikaite J; Bumelis VA Biochimie; 2009 Sep; 91(9):1123-30. PubMed ID: 19524011 [TBL] [Abstract][Full Text] [Related]
36. [Gene analysis of a combined inherited factor VII and factor X deficiency pedigree]. Wang MS; Jin YH; Zheng FX; Xie HX; Xu PF; Niu ZZ Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):854-7. PubMed ID: 22339961 [TBL] [Abstract][Full Text] [Related]
37. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Herrmann FH; Wulff K; Auerswald G; Schulman S; Astermark J; Batorova A; Kreuz W; Pollmann H; Ruiz-Saez A; De Bosch N; Salazar-Sanchez L; Haemophilia; 2009 Jan; 15(1):267-80. PubMed ID: 18976247 [TBL] [Abstract][Full Text] [Related]
38. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor. Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921 [TBL] [Abstract][Full Text] [Related]
39. Factor VII R110C: a novel missense mutation (Arg110Cys) in the second epidermal growth factor-like domain causing factor VII deficiency in members of a Japanese family. Suto M; Uchiumi H; Tsukamoto N; Nojima Y; Tamura J; Naruse T Blood Coagul Fibrinolysis; 2000 Jul; 11(5):415-9. PubMed ID: 10937801 [TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical aspects of factor VII deficiency. Mariani G; Lo Coco L; Bernardi F; Pinotti M Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S83-8. PubMed ID: 9819034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]